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The Toxicologic Effects of the Carbamate
Insecticide Aldicarb in Mammals: A Review
by John F. Risher,* Franklin L. Mink,* and Jerry F. Stara*
Aldicarb, 2-methyl-2-(methylthio)propionaldehyde-0-methylcarbamoyloxime, is an oximecarbamate in-
secticide manufactured by the Union Carbide Corporation and sold under the trade name Temik. It is a
soil-applied systemic pesticide used against certain insects, mites, and nematodes, and is applied below
the soil surface for absorption by plant roots. It is generally applied to the soil in the form of 5, 10, or
15% granules, and soil moisture is essential for the release of the toxicant. Uptake by plants is rapid.
Aldicarb is currently registered for use on cotton, sugar beets, sugar cane (Louisiana only), potatoes,
sweet potatoes, peanuts, oranges, pecans (Southeast only), dry beans, soybeans, and ornamental plants.
Home and garden use is not permitted.
Discovery of aldicarb and its oxidative sulfoxide and sulfone metabolites in well or ground water in
Florida, Wisconsin, and New York, and accidental poisonings from ingesting contaminated watermelons
and cucumbers in the South and West have spurred interest and concern about this pesticide.
The primary mechanism of toxic action of aldicarb is cholinesterase inhibition. However, unlike the
relatively irreversible anticholinesterase activity of the organophosphate pesticides, the carbamylation
process which produces the anti-AChE action is quickly reversible. Aldicarb is readily absorbed through
both the gut and the skin, but is rapidly metabolized and excreted in the urine almostly completely within
24 hr. Although it is acutely toxic to humans and laboratory animals, aldicarb is not known to be carcin-
ogenic, teratogenic, conclusively mutagenic, orto produce otherlong-term adverse health effects. In cases
ofaccidental poisoning, thecholinergic symptoms havegenerally subsided within 6 hr, with no side effects
or complications.
Introduction
Aldicarb, 2-methyl-2-(methylthio)propionaldehyde 0-
(methylcarbamoyl)-oxime, is an oxime carbamate in-
secticide produced by the Union Carbide Corporation
under the code number "UC 21149," trademark
"Temik," and has the structural formula:
CH3 H 0
11
CH3-S-C -C=N-O-C-N -CH3
CH3 H
Aldicarb is relatively soluble in water and most organic
solvents. It is a stable compound, except in strong al-
kaline solutions, and is nonflammable and noncorrosive
to metal.
Aldicarb is asystemicpesticide used against avariety
ofinsects and nematodes. The insecticide is applied be-
lowthesoilsurfaceforabsorptionbyplantrootsystems,
and moisture is required to release the toxicant from
granules. Aldicarb is currently registered for use on a
variety of crops, including cotton, sugar beets, sugar
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cane, certain citrus fruits, potatoes, sweet potatoes,
peanuts, and ornamental plants; it may generally pro-
videplantprotection foraperiod ofupto 12weeks after
application, depending on soil and climatic conditions.
The half-life ofaldicarb varies from approximately 1 to
2 weeks under laboratory conditions, but may be much
shorterinthefield orlongerifitleachestogroundwater
or if cool, nonalkaline conditions prevail.
Absorption, Metabolism, and
Excretion
While it is not the intent ofthis article to provide an
in-depth presentation ofthe metabolism ofaldicarb and
its pathways in man and animals, the authors feel that
a brief discussion of this area would facilitate the un-
derstanding of the toxicological properties and health
impacts ofthis insecticide.
Anumberofstudieshavedemonstratedthataldicarb,
-as well as its sulfoxide and sulfone metabolites, is ab-
sorbed readily and almost completely through the gut
inavarietyofspecies(1-5). Dermalabsorptionhasbeen
reported in rabbits (6,7) and rats (8) and might be ex-
pected to present a problem to unprotected humans in
manufacturing and field application settings.
The rapidity of gastrointestinal absorption is illus-
tratedinastudybyCambonetal. (5), whoadministeredRISHER, MINK, AND STARA
by gastric intubation single doses of 0.001, 0.01, and
0.10 mg aldicarb (analytical grade 99%) per kg body-
weight to pregnant Sprague-Dawley rats. Signs ofpoi-
soning occurred approximately 5 min after the admin-
istration of the larger doses, indicating the speed of
uptake from the gut.
The extent ofabsorption, metabolism, and excretion
ofaldicarb hasalsobeendocumented innumberofother
studies. Andrawes et al. (2) administered oral doses of
radiolabeled Temik and Temik sulfoxide to female rats
and observed 80 to 90% excretion ofthe isotope in the
urine and 2 to 5% in the feces within the first 24 hr
following administration. Only trace amounts ofTemik
were found in the exereta, attesting to the high degree
ofabsorption. Anotherstudyprovided furtherevidence
ofthe rapidity and completeness ofaldicarb absorption
(1). Following oral administration of Temik labeled in
three separate positions, the researchers reported that
Temik was rapidly absorbed from the gastrointestinal
tract. Bythe end ofthe first 24 hr afteradministration,
approximately 90% of two of the labels had been ex-
creted in the urine or as CO2. When rats were fed milk
containing radiolabeled Temik metabolites daily for 9
days, approximately 90% ofeach dose was reported to
have been excreted in the urine within a 24-hr period
(3). Similarly, Dorough et al. (4) fed Holstein cows var-
ious concentrations ofTemik in the diet and found that
92, 3, and 1% of the dosages were eliminated in the
unne, feces, and milk, respectively, indicating almost
complete absorption of the administered dose through
the gut.
Studies examined in the preparation of this review
indicate that aldicarb is widely distributed throughout
thecontaminated organism. However, sinceitisrapidly
metabolized, invasion of individual tissues is generally
temporary, given noncontinuous exposure.
Andrawes et al. (2) administered oral doses of ra-
diolabeledS' Temikto female rats at a level of0.4 mg/
kg. At designated times (5-11 days following treat-
ment), two rats were killed and tissue samples were
removed and frozen for future analysis. Tissues ana-
lyzed included blood, heart, kidneys, brain, lungs,
spleen, liver, leg muscle, fat, bone, stomach, and small
and large intestine. Analysis of the tissue samples in-
dicated a general distribution of radioactive residues,
and there was no indication that any particular tissue
or group of tissues was selective in sequestering aldi-
carb or its metabolites.
The metabolism of aldicarb involves both hydrolysis
ofthe carbamate ester and oxidation ofthe sulfurtothe
sulfoxide and sulfone derivatives (2). While the hy-
drolysis results in compounds with little or no insecti-
cidal activity or toxicity to other organisms, the sulf-
oxide and sulfone metabolites are active cholinesterase
inhibitors (2,9,10). Figure 1 shows the metabolic path-
ways ofaldicarb in the rat (11). Aldicarb metabolites in
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FIGURE 1. Metabolic pathways of aldicarb metabolism in rats. Source: Modified from Wilkinson et al. (11).
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animals include aldicarb sulfoxide, aldicarb sulfone, ox-
ime sulfoxide, oxime sulfone, nitrile sulfoxide, nitrile
sulfone, and at least five other metabolites (1,4).
Further investigation of the metabolism of aldicarb
was reported in a study of the metabolic fate of the
insecticide Temik labeled at three different positions
(either S-methyl-C14, t-butyl-C14, orN-methyl-C14) (1).
In this experiment, male Carworth Farms-Elias stock
rats were administered 50 ,ug oral doses (equivalent to
0.33 mg/kg body weight) of radiolabeled Temik dis-
solved in polyethylene glycol 400 using the weighed sy-
ringe technique. Each labeled compound was adminis-
tered to eight animals. In addition, groups offour rats
per radiolabel were similarly administered 10 mg (66
mg/kg bodyweight) ofthe S-methyl-C14 and t-butyl-C14
oxime analogues. Results of this study indicated that
Temikismetabolized inthe ratand excretedinthefirst-
day urine as Temik sulfoxide (- 40%), oxime sulfoxide
(- 30%), and 5 to 9 other polar compounds (- 30%),
believed to be acids. Essentialiy all of the test com-
pounds administered were metabolized bythe rat. Only
tracequantitiesofTemik(- 1%)andofoximeandoxime
sulfone (- 1-2%) could be found in the urine. Evidence
ofTemik sulfone could not be found by either gas, silica
gel, or thin layer chromatography.
The metabolism ofaldicarb has also been studied ex-
perimentally in cows (3). The results of this study in-
dicated that the metabolic pathway of the insecticide
Temik in dairy animals is similar to that reported for
other animal species. Additional detailed reports ofthe
specific metabolic pathways for aldicarb are available in
the published literature (2,12-14).
As previously discussed, the elimination of aldicarb
and its metabolites has been studied in a variety of
species including rats (1-3,15) and cows (3,4). In all
studies reviewed, the primary means ofaldicarb excre-
tion was found to be viathe urine. Respiratory CO2 and
feces are other minor avenues through which this in-
secticide and its metabolites are eliminated from ex-
posed animals. Enterohepatic recirculation of aldicarb
and/or its metabolites has been demonstrated by Mar-
shall and Dorough (15), who suggested that in intact
rats (study performed with cannulated bile ducts), the
majority ofthe biliary metabolites are reabsorbed from
the intestine and ultimately excreted in the urine.
Summary
Aldicarbisreadilyabsorbedthroughthegutandskin.
It is rapidly metabolized and excreted within 24 hr of
exposure, with urine accounting for almost ali of the
excreted toxic and relatively nontoxic (oxime and ni-
trile) metabolites.
Health Effects Studies Using
Animals
Acute Toxicity
The National Academy of Science reports that the
acute toxicity ofaldicarb is probably the highest of any
widely used insecticide (10). Table 1 provides LD5o val-
ues for aldicarb in a variety of species.
The acute toxicity ofthis insecticide has been studied
in a variety of laboratory mammals, including rats
(8,16-21), mice (22), and rabbits (18).
Gaines (8) administered technical grade aldicarb as
single doses in peanut oil via stomach tube or dermally
as a solution in xylene to adult Sherman rats of both
sexes. Female rats were found to be slightly more sen-
sitive to Temikthanweremales. OralLD50valueswere
determined to be 0.8 and 0.65 mg/kg body weight for
males and females, respectively. Reported dermal LD50
values were 3.0 mg/kg body weight for males and 2.5
mg/kg for females. The lowest doses reported to have
killed rats were 0.5 mg/kg body weight for oral admin-
istration and 2.0 mg/kg body weight for the dermal
route foranimals ofboth sexes. Otheroral LD50studies
produced similar, but slightlyhigher, valuesinrats (see
Table 1). LD50values foraldicarb sulfoxide and aldicarb
sulfone were determined to be 0.88 mg/kg body weight
and 25.0 mg/kg, respectively, in another study in rats
(19).
Whenaldicarbwasadministered orallyusingavehicle
other than peanut or corn oil, the LD50 values were
somewhat higher. Weil (20) found the acute oral LD5o
for Temik lOG to be 7.07 mg/kg body weight in rats
Table 1. Acute toxicity ofaldicarb.
Route of Organism/ Refer-
LD50 administration strain Vehicle ence
0.93 mg/kg Oral Rats (7,16)
0.8 mg/kg Oral Sherman rats Peanut oil (8)
(males)
0.65 mg/kg Oral Sherman rats Peanut oil (8)
(females)
0.9 mg/kg Oral Rats Corn oil (17)
(males) (unspecified
type)
1 mg/kg Oral Rats Corn oil (18)
(females) (unspecified
type)
3 mg/kg Dermal Sherman rats Xylene (8)
(males)
2.5 mg/kg Dermal Sherman rats Xylene (8)
(females)
0.3-0.5 mg/kg Oral Swisswhitemice (22)
5.0 mg/kg Dermal Rabbits Propylene (16)
glycol (5%
solution)
5.0 mg/kg Dermal Rabbits (18)
32 mg/kga Dermal Rabbits Water (50% (23)
solution)
12.5 mg/kge Dermal Rabbits Dimethyl (18,23)
phthalate
3.5 mg/kg" Dennal Rabbits Toluene (5% (18,23)
solution)
141 mg/kga Dermal Rabbits Nonec (24,25)
0.44 mg/kg IP Rats (21)
(unspecified
type)
1.60mg/kge Oral Deer mice (26)
a24-hr exposure.
b4-hr exposure.
CDry Temik lOG applied to skin under adhesive tape.
dReported as approximate lethal dose (ALD), not an LD. value.
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when the insecticide was administered as dry granules.
Carpenter and Smith (17) placed 1 g of Temik lOG in
200 mL of water for 8 hr and then administered the
formulation torats. Theresulting LD50was determined
to be 6.2 mg/kg body weight.
In addition to the study by Gaines (8) mentioned pre-
viously, the dermal toxicity to rats has been investi-
gated in at least two other studies. Carpenter and
Smyth (17) conducted 4-hrskinexposure testswithrats
byusingTemik lOGapplied asbothdryformulation and
with saline added. Following the 4-hr exposure period,
in which the test materials were taped to the skin, the
dry formulation was found to be not as toxic as was the
same mixture when wetted with saline. The respective
LD50 values were 400 mg/kg body weight for the mois-
tened mixture and 3200 mg/kg for the dry application.
Weil (20), in a similar experiment, applied dry granules
of Temik lOG or Temik 15G to the bellies ofrats for 4
hr and found the LD50 values to be 4.58 and 6.32 g/kg
body weight for the 10% (1OG) and 15% (15G) formu-
lations, respectively. The significance ofthe specific ve-
hicle in dermal applications ofaldicarb is evident in Ta-
ble 1.
In inhalation studies using rats, mice, and guinea
pigs, a concentration of 200 mg aldicarb dust/i was
found to be highly toxic to all three species in a 5-min
exposure (17). At this level, rats and mice were ob-
served to be more susceptible to the dust than were
guinea pigs. The survival at a given concentration was
found to vary with time. While rats appeared to be
capable of surviving an aldicarb dust concentration of
6.7mg/i3 for 15min, five ofsixwere killed bythe same
concentration in 30 min. By contrast, rats were able to
survive 8 hr in atmospheres of saturated aldicarb va-
pors. It appears that aldicarb is somewhat less toxic as
an aerosol than a dust, as attested by the observation
thattwoofsixratswereabletosurvive an8hrexposure
to a7.6mgaldicarb/m3 aerosol. Whenthe concentration
oftheaerosolwasraised to 15mg/m3, five ofsixanimals
exposed died within 4 hr.
A much larger number of short-term studies have
been conducted using higher doses and a broader va-
riety oftest species. Weil and Carpenterreported a 93-
day study (27) in which aldicarb was administered in
the diet ofCatworth Farms-Elias male and female rats
at dosages of0, 0.02, 0.1, and 0.5 mg/kg/day. A signif-
icant increase in mortality (cause not specified) was
noted at the high dose; mortality was further reported
to benumerically, but not significantly, increased atthe
0.1 mg/kg/day level. On examination ofpathology, the
organ weights and plasma, erythrocyte, or brain cho-
linesterase levels in survivors at all dosage levels were
found not to differ from controls. When aldicarb was
fed at a level of 3.2 mg/kg/day, body weights of males
and females were depressed, while liver and kidney
weights were not. Plasma cholinesterase activity was
depressed in both males and females, but a reduction
in erythrocyte cholinesterase activity was observed
only in males.
In a shorter duration studywith rats (28), the effects
ofaldicarb, aldicarbsulfoxide, andaldicarbsulfonewere
examined on groups of 10 (5 males and 5 females each)
rats. Commencing when the rats were 45 days of age,
the groups were administered the test compound in the
feed for 7 days at dosages including0.4, 1.0, 2.5, or 5.0
mg/kg/day. Parametersinvestigatedincludedeffects on
body weight, liver and kidney weights, and brain,
plasma and erythrocyte cholinesterase activity. Rats
were said to tolerate > 0.4 mg aldicarb sulfoxide/kg/
day without effects on body weight, liver and kidney
weight, or depression ofbrain, plasma, or erythrocyte
cholinesterase. Aldicarb sulfone was found to depress
brain, plasma, anderythrocytecholinesterase at5.0mg/
kg body weight. A statistically signficant decrease in
brain cholinesterase was observed in female rats ad-
ministered the 2.5 and 1.0 mg/kg body weight dosages.
Only limited information was available for this study
(40).
DePass et al. reported the administration of a 1:1
mixture of aldicarb sulfoxide and aldicarb sulfone in
drinking water to young Wistar rats (29). Groups con-
sisting of 10 animals of each sex were provided water
containing nominal concentrations of 19.2, 4.8, 1.2, 0.3,
0.075, or 0.0 ppm ofthe treatment mixture. Individual
dosage levels, based on the nominal concentrations
used, and initial weights ofthe animals, ranged from 0
to 1.67 mg/kg/day for males and from 0 to 1.94 mg/kg/
day for females. Blood samples were taken after 8, 15,
and 29 days oftreatment and were analyzed forplasma
and erythrocyte cholinesterase levels. Brain cholines-
terase determinations were made at sacrifice (29 days
after initiation oftreatment).
Plasma cholinesterase was reduced 65 to 77% (de-
pending on the sex of the animal and the day of blood
sampling) in all animals at the 19.2 ppm dosage. The
4.8ppmtreatmentlevelofthesulfoxide-sulfone mixture
was reported to cause a statistically significant (28%
mean) reduction in plasma cholinesterase only in male
rats and only on one sampling date, after 8 days of
treatment.
RBC cholinesterase activity was likewise reduced at
all sampling periods in all 19.2 ppm-treated rats, with
reported decreases ranging from 48 to 63%, again de-
pending on the sex ofthe animal examined and the date
of the sample. A reduction of 24% erythrocyte cholin-
esterase was further observed in males at the 4.8 ppm
dose level following 29 days ofexposure. No inhibition
was observed at any ofthe lower concentrations.
The only reported statistically significant reduction
in brain cholinesterase was a 10% decrease in female
ratsfollowing29daysoftreatmentatthehighestdosage
level. Malesexperienced asimilardecreaseinbraincho-
linesterase activity, but, because ofthe greater varia-
bility of the data, the reduction was not found to be
statistically significant. No mortality or symptoms of
acetylcholinesterase inhibition were observed.
Body weight gain and water consumption were also
reported to be reduced significantly in both sexes at 7,
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14, 21, and 29 days into treatment, as was food con-
sumption during the same time in males; however, the
authors indicated that the body weight effect may have
been the result oflower palatability ofthe test solution
at the highest concentration, rather than a toxic effect.
In consideration oftrue toxic effects in this study, it
shouldbenoted thattheauthorsreportedthatthemean
concentration of sulfoxide plus sulfone was only ap-
proximately 86% of the nominal values when the solu-
tions were first given to the rats, a phenomenon attrib-
uted to degradation occurring prior to administration
to the animals. Additionally, after 1 week in water bot-
tlesatroomtemperature, themeanconcentrationswere
further reduced to only 73% of the nominal values
(which might mean that the observed effects were ac-
tually seen at lower than the nominal dosages). The
authors concluded that, while substantial effects re-
sultedfromexposure oftheratstothe 19.2ppmnominal
dosage, the treatment effects of reduced plasma and
erythrocyteacetylcholinesterase activityinmales atthe
4.8 ppm dosage (0.47 mg/kg body weight) during only
1 of the 3 sampling periods were of questionable bio-
logical significance, and therefore termed the concen-
tration of4.8 ppm in the drinking water a "no-ill-effect
level" for aldicarb residue exposure in the rat.
It was further noted that the 24 to 28% reduction in
acetylcholinesterase activity observed at this dosage
generally does not cause symptoms of intoxication in
humans (30). If the observed reduction in plasma and
erythrocyte cholinesterase activityinthe4.8ppmmales
were to be considered an adverse orill effect, however,
the no-observed-adverse-effect level (NOAEL) would
be considerably lower (1.2 ppm, or 0.12 mg/kg body
weight). It should be noted that the use ofthe 1:1 mix-
ture of aldicarb sulfoxide and aldicarb sulfone in this
study was based on a 1983 Cornell University report
(11), which noted that residues found in drinking water
are generally present in a 1:1 mixture of sulfoxide to
sulfone. Giventheknownhighertoxicityofthesulfoxide
moiety, alowerNOAELmightbeexpectedfromsimilar
administration ofthe sulfoxide alone.
Dorough et al. administered Temik in the diet oflac-
tating Holstein cows in a two-part experiment (4). In a
pilot study to determine the effect ofTemik on the gen-
eral health of a cow, a single 645 kg cow was given
Temik and Temik sulfone at a rate equivalent to 1.2
ppm Temik (0.042 body weight) in the diet for 10 days.
Daily blood samples were drawn 6 hr after the morning
milking and immediately assayed for RBC and plasma
cholinesterase activity. The animal was milked at 12-hr
intervals. The results ofthis pilot study indicated that
feeding a dairy cow 1.2 ppm Temik equivalents would
notcauseanyvisibleilleffectstotheanimal. Theresults
ofthese assaysindicatedthatbloodcholinesteraselevels
were not reduced by the treatment, and quantitative
milk production remained constant during the treat-
ment.
In the second part of the same study, Dorough and
his co-workers fed three cows separate dosages of a
Temik-Temik sulfone combination for 14 days. The
treatment dosages were administered twice daily with
a balling gun at 12-hr intervals in the fonn ofa gelatin
capsule containing crushed grain. Individual doses of
Temik equivalents were 0.12 ppm (0.006 mg/kg body
weight) forone cow, 0.6ppm (0.027mg/kgbodyweight)
for the second cow, and 1.2 ppm (0.052 mg/kg body
weight) for the third. As in the pilot study, blood was
taken from each animal on a daily basis throughout the
treatment period. The blood was drawn 6 hr after the
morning milking and immediately assayed for plasma
and RBC cholinesterase activity. All animals were
milked regularly at 12-hrintervals. In this experiment,
no apparent harmful effects were noted in any of the
test animals. Regardless of the level of administered
dose, blood cholinesterase levels were the same both
beforeand duringtreatment. Milkproduction, feed con-
sumption, and quantity ofexcretory products were re-
ported to have remained stable throughout the exper-
iment. The authors concluded that, with only minor
exception, the continuous exposure ofdairy animals to
Temik in the diet does not significantly alter the com-
pound's fate, compared to single exposure.
CarpenterandSmythreportedthedosingofcatswith
0.5, 1.0, or 1.5 mg aldicarb/kg/day for multiple doses,
with a 7 to 8 day interval between doses (17). These
authors reported no evidence oftolerance through con-
tinued exposure, as death following administration of
the third dose was as prompt as the death observed
after administration ofthe first dose.
The potential severity ofacute toxic poisoning by al-
dicarb is evidenced by a reported incident (31) in which
six cows became ill and two ofthe six died followingthe
accidental spilling of Temik in a pasture. Chemical
analysis for aldicarb in the rumen of one of the dead
animals showed that a lethal dose ofthe pesticide was
present. Milk produced bythe survivinganimals on the
day ofthe poisoning and the next 6 successive days had
to be destroyed to prevent possible human health risks.
The toxic effects of short-term dermal exposure to
aldicarb have also been investigated (24,25,32). Car-
penter and Smyth investigated the toxic effects of al-
dicarb administered dermally for a period of 15 days
(24). In this study, Temik lOG (10.5% active granular
formulation) was administered tomale albinorabbitsby
application ofwetted gauze to abraded skin areas for 6
hr/daythroughaconsecutive 15-dayperiod. Dosagelev-
els of 0.05, 0.10, and 0.20 g/kg were tested. Criteria
used to assess the toxicity of Temik were total weight
gain, food consumption, liver and kidney weights,
plasmaand erythrocytecholinesterase activity, andhis-
topathologicalexamination ofliver, lung, kidney, heart,
muscle, thyroid, andsldntissue. Acourseofhematology
was also run, as were kidney function (blood urea ni-
trogen) and liver function (serum glutamic oxalacetic
and pyruvic transaminase) tests. The only parameter
significantly affected was body weight gain, as de-
pressedgainswereobservedinthegroupsadministered
0.1 and 0.2 g Temik/kg. Plasma cholinesterase activity
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was also reported to be depressed at these treatment
levels.
Chronic and Subchronic Effects
Although a number offeeding studies of3 months or
lessdurationhavebeenconducted (4,17,27,28), onlyfive
long-tern (chronic) studies could be located inthe-avail-
able literature (33-37). Table 2 summarizes the data
from available long-term and significant short-term
studies.
Welland Carpenter(33)studiedtheeffects ofaldicarb
administered inthe diet ofrats ofanunspecified variety
over a 2-year period. Four groups of rats, each group
consisting of20 males and 20 females, were maintained
on diets containg aldicarb at levels of 0.005, 0.025,
0.05, or 0.1 mg/kg for 2 years. A control group of the
same size was fed a similar diet without the aldicarb.
Concurrently, 32 rats per group (16 of each sex) were
fed each diet for observation ofshorter term effects. In
this concurrent experiment, four animals of each sex
were sacrificed following the sixth month ofthe exper-
iment, and the remaining 12 rats ofeach sex were killed
at the end of 1 year. Based upon measurements offood
consumption, mortality and lifespan, incidence ofinfee-
tion, liver and kidney weights as percentage of body
weight, body weight gain, maximum body weight, he-
matocrit, incidence ofneoplasms, incidence ofpatholog-
ical lesions, and brain, plasma, and erythrocyte cholin-
esteraselevels, thealdicarb-treated animals werefound
not to differ significantly from controls for any ofthese
parameters. The results of the 2-year feeding portion
ofthis study are reported later in this paper.
Another long-term feeding study in rats has been
reported by Weil and Carpenter (34). In this experi-
ment, groups of 20 Greenacres Laboratory Controlled
Floraratsofeach sex were fedlevelsof0.3 mgaldicarb/
kg/day, 0.3 or 0.6 mg aldicarb sulfoxide/kg/day, 0.6 or
2.4 mg aldicarb sulfone/kg/day, or 0.6 or 1.2 mgof a 1:1
mixture of aldicarb sulfoxide and aldicarb sulfone/kg/
dayfor up to 2 years. Noadverse effects were observed
atthe0.3 mgaldicarb/kg/daytreatmentlevel. However,
the high dose ofthe aldicarb sulfoxide, aldicarb sulfone
mixture resulted in increased mortality within the first
30 days, as well as a decrease in plasma cholinesterase
activity and decreased weight gain in males. Some in-
crease in mortality was also reported for females re-
ceivingthe 0.6 mg/kg/day aldicarb sulfoxide treatment.
No-observed-adverse-effect levels determined in this
study were 0.3 mg/kg/day for aldicarb, 0.3 mg/kg/day
for aldicarb sulfoxide, 2.4 mg/kg/day for aldicarb sul-
fone, and 0.6 mg/kg/day for the 1:1 mixture ofaldicarb
sulfoxide and aldicarb sulfone.
Weil and Carpenter reported the results of a 2-year
study in which beagle dogs were administered aldicarb
(99.9% pure) inthe diet (35). Four groups ofdogs, three
males and three females each, were fed dosages of al-
dicarb equivalent to 0, 0.1, 0.05, or 0.025 mg/kg/day.
Based upon observations of body weight changes, ap-
petite, mortality, histopathology, hematology, biochem-
istry, andterminalliverandkidneyweights, there were
no statistically significant deleterious effects found at
any ofthe administered dosages. The no-effect level of
Table 2. Long-term studies of aldicarb and its oxidative metabolites.
Dose, Route of
mg/kg/day Duration administration Organism/strain Effects Reference
0.la 2 years Oral Rats (unspecified None (33)
strain)
0.1 13 weeks Oral CFE rats No adverse effects (27)
0.5 13 weeks Oral CFE rats Significant increase (27)
in mortality
0.3a 2 years Oral Greenacres No adverse effects (34)
Laboratory
controlled rats
0.3 2 years Oral (aldicarb Greenacres No adverse effects (34)
sulfoxide) Laboratory (some deaths in
controlled rats females at 0.6
mg/kg/day dosage)
2.4a 2 years Oral (aldicarb Greenacres No adverse effects (34)
sulfone) Laboratory
controlled rats
0.6 2 years Oral (1:1 aldi- Greenacres No adverse effects (34)
carb sulfoxide: Laboratory (increased mortality
sulfone mixture) controlled rats within 30 days at
1.2 mg/kg/day)
o.la 2 years Oral Beagle dogs None (35)
0.125 6 months Oral (aldicarb Rats (unspecified None (36)
sulfoxide) strain)
0.12 29 days Oral (drinldng Wistar rats None (29)
water-1:1 sul-
foxide/sulfone
ratio)
aHighest dose administered.
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0.1 mg/kg/day for dogs is identical to the 0.1 mg/kg/day
level determined for rats in the Weil and Carpenter
experiment (33) described previously, as well as in 90-
day dog studies (38). It should be noted, however, that
neither ofthese Weil and Carpenter studies tested dos-
ages above the 0.1 mg/kg/day level.
Instudiesusingdosagesmoresuitablefortheanalysis
ofcholinesterase inhibition (36,37), Weil and Carpenter
administered aldicarb sulfoxide or aldicarb sulfone in
the diet to rats at dosage levels of 0, 0.125, 0.25, 0.5,
or 1.0 mg sulfoxide/kg body weight or 0, 0.2, 0.6, 1.8,
5.4, or 16.2 mg sulfone/kg body weight. Groups of 15
animals ofeach sex were fed these aldicarb metabolites
for a period of 6 months. Animals were sacrificed fol-
lowing3or6monthsoftreatmentfortissueexamination
and measurement of brain, plasma, and RBC cholin-
esterase activity. Theresults ofboththe3- and6-month
studies clearly indicated a substantial reduction (rela-
tive to controls) of cholinesterase levels at the three
highest dosage levels for each compound when meas-
ured immediately upon cessation of feeding. The rela-
tiveorderofcholinesterasedecreasewasplasma > RBC
> brain. No mortality or gross or microscopic tissue
effects were noted, despite the reported substantial de-
crease in cholinesterase levels; however, some growth
retardation was reported at the highest treatment dos-
ages.
Using similar dosing regimens of aldicarb sulfoxide
and sulfone for a 3-month treatment period, Weil and
Carpenter (36,37) investigated cholinesterase activity
depression in animals either sacrificed immediately
upon cessation of feeding or placed on a control diet
duringa1-dayrecoveryperiod. Theresults ofthisstudy
indicated a rapid recovery from the cholinesterase in-
hibition for all but the highest dosage levels for both
test compounds. These studies have been used by the
World Health Organization Committee on Pesticide
Residues to arrive at a0.125 mg/kgbodyweight NOEL
for aldicarb sulfoxide in the rat (39).
Carcinogenicity
Aldicarbhasbeenfoundtobenoncarcinogenic tomice
inaskinpaintingstudy(41)andnoncarcinogenic tomice
and rats infeedingstudies (33,42) atthedosages tested.
A summary of these negative studies is presented be-
low.
Weil and Carpenter conducted a skin painting study
using male C3H/H3J mice (41). Female mice were not
employed for this test due to the incidence of sponta-
neous mammary tumors, particularly in breeding fe-
males. Mice were administered aldicarb in the forn of
applications of a 0.125% concentration to hair-free skin
on the backs ofthe animals twice per week for up to 28
months. When compared with controls (positive control
group painted with cholanthrene), aldicarb was deter-
mined to benoncarcinogenic underthe conditions ofthe
experiment.
In a 2-year feeding study (33), equivalent doses of
0.005, 0.025, 0.05, or 0.1 mg aldicarb/kg/day were ad-
ministered in the diet to an unspecified strain of rats.
The incidences of tumors were determined not to be
significantly greater than those of control groups. No
adverse effects were also reported in Greenacres Lab-
oratory Controlled Flora rats fed 0.3 mg/kg/day for 2
years (34), although it is not clear whether this partic-
ular experiment was designed specifically as an onco-
genicity study.
The National Cancer Institute (NCI) conducted a
bioassay of aldicarb for possible carcinogenic effects in
rats andmice (42). Testgroupsof50male and 50female
F344 rats, and the same numbers, of male and female
B6C3F1 mice were administered doses ofeither 2 or 6
ppm in a diet containing2% corn oil for 103 weeks. The
animals were then observed for an additional 0 to 2
weeks and killed. Matched controls were 25 untreated
rats and 25 untreated mice ofeach sex. No tumors that
could be clearly determined to be the result of the al-
dicarb administration occurred in either the rats or
mice.
In the NCI bioassay, dose-related adenomas or car-
cinomas of the pituitary were observed in female rats
(p = 0.048); however, the incidences of these tumors
were not significantly higherthanthose observed inthe
corresponding control group. Similarly, fibrosarcomas
or sarcomas of subcutaneous tissue were observed in
malemiceatincidencesthatappeared tobedoserelated
(p = 0.043), but these tumor incidences were not sig-
nificantly higher than in the corresponding control
group. It should be noted thattheincidence ofpituitary
tumors in historical-control female F344 rats atthe lab-
oratory conducting the bioassay was also high. Conse-
quently, the occurrence of the pituitary tumors in fe-
male rats and subcutaneous tissue tumors ofmale mice
could not be clearly related to the aldicarb administra-
tion. Sincenotumorsoccurredatstatistically significant
levels in eitherthe rats ormicetested, itwas concluded
that under the conditions of the bioassay, technical
grade (99+%) aldicarb was not carcinogenic for F344
rats or B6C3F1 mice of either sex.
Quarles etal. tested anumberofpesticides, including
aldicarb, fortransformingandtumorigenicactivity(43).
The purity ofaldicarb was indicated to be greater than
95%. In the host-mediated assay portion ofthis study,
pregnant hamsters were given IP injections of0.001 or
0.005mgaldicarb/kgbodyweightadministered inanon-
transforming solvent. Injections were given on day 10
of gestation, and fetal cell cultures were prepared on
day 13. In evaluation ofthis test, colonies were consid-
ered to have been transformed if the cells had clearly
lost orientation and were criss-crossed ormultilayered.
When cultures were plated for plating efficiency and
determination oftransformation, cells were also tested
for growth in 0.3% agar.
To test for tumorigenicity, approximately 106 trans-
formed or untransformed cells were injected SC into
young adult nude (athymic) mice. These 4- to 6-week-
old mice were then maintained in groups of 3 to 6 per
standard polycarbonate cage and observed for 6 to 12
months for tumor formation.
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To test for spontaneous transformation, fetal cell cul-
tures were handled at intervals throughout the study
and examined according to standard test procedures.
Ofnearly 38,000 colonies examined, none revealed evi-
dence of morphological transformants, and no growth
ofcells in 0.3% agarwas observed. Therefore, the spon-
taneous transformation rate was determined to be in-
significant in this assay. The solvents used in this ex-
periment were similarly tested, and of approximately
22,000 colonies examined, no induction ofmorphological
transformation or growth of cells suspended in 0.3%
agar was observed following treatment of pregnant
hamsters with the test solvents.
For the transplacental host-mediated assay, dosages
chosen (0.001 and 0.005 mg/kg body weight) were the
greatest nonlethal doses tested that did not exceed 0.3
mg/kg bodyweight. Aldicarb showed no transforming
activity at the dosages tested. It produced no growth
at 0.005%, but was not tested at 0.001 mg/kg. When
clones isolated from subcultures 5 to 7 were tested for
tumorigenicity in nude mice, none of the four mice in-
oculated developed tumors. The reseachers concluded
that aldicarb was inactive and induced neither mor-
phological transformants nor cells that grew in agar.
Similar tests with nitrosoaldicarb produced contrasting
results, butonlyaldicarbwillbe discussed inthispaper.
Mutagenicity
Although conclusive evidence concerning the muta-
genic potential of aldicarb is not yet available, two re-
cent studies suggest that this insecticide might have
mutagenic potential. In the first study, Cid and Matos
investigated the effects of aldicarb on human lympho-
cytes invitro inthe presence ofan exogenous metabolic
activation system by means of an analysis of sister-
chromatid exchange (SCE) and mitotic delay (44). In
this study, cyclophosphamide (CP) was used as a pos-
itive control to compare the chromosomal effects of al-
dicarb with a known genotoxic agent. Data obtained
from this study revealed that aldicarb, as well as CP,
induced a significant increase of SCE values in the ab-
sence of S9 mix, leading the authors to suggest that
metabolic activation ofaldicarb seemsto occurinhuman
blood cultures. Treatment with aldicarb in the presence
ofthe S9mixwasreportedtoinduceSCE valuesslightly
higher than those obtained with aldicarb alone. This,
the authors state, could be construed to indicate aweak
activation of aldicarb by the exogenous metabolic sys-
tem. Furthermore, S9 mix was reported to apparently
potentiate the cytotoxiceffects ofaldicarb, as evidenced
by the observation of only a few metaphases in blood
cultures treated with the highest dose ofaldicarb alone;
no metaphases were observed in cultures treated with
the same concentration of aldicarb plus S9.
In the second study (45), Sharaf et al. investigated
chromosomal aberrations in male albino rats. The ani-
mals received IP injections of 0.00121, 0.00666, or
0.0121 mg/kg body weight of aldicarb in a 1:1 acetone
and water vehicle. Controls received only the ace-
tone:water solution. Subacute (1 injection per day for 5
days) and acute (sacrifice 6, 24, or 48 hr following a
single injection) phases of the experiment were con-
ducted. Bone marrow cells ofrat femurswereanalyzed,
and increases in both structural and numerical aber-
rations were observed in all animals treated with aldi-
carb. Significant structural chromosomal aberrations
were observed in the form of chromatid breaks and
gaps, centric fusions, centromeric attenuation, and end
to end association, suggestive of chromosomal damage
occurring during the G1 stage of the cell cycle. The
numerical aberrations were primarily due to polyploidy
and endomitosis, the latter indicating a specific effect
ofthe insecticide on the mitotic spindle, and leading to
the observed concomitant increase in the mitotic index
at all stages. The highest increase in numerical aber-
rationswasobservedfollowingsubacutetreatmentwith
the maximum tolerated dose. The authors suggested
that aldicarb may have a cumulative effect and may be
a clastogenic agent in rats.
In contrast, U.S. EPA (40) cited an unpublished re-
port (46) indicatingthat 0.7mgaldicarb/kgbodyweight
ofrats caused no adverse effects in the dominant lethal
mutagenicity test. Ercegovich and Rashid evaluated 70
pesticides and their related degradation products for
mutagenic effects in five strains of Salmonella typhi-
murium, employing the procedures of the Ames test,
and found aldicarb tobe weaklymutagenic onlywithout
activation by liver microsomal enzymes (47). Belvins et
al. (48), Seiler (49), and others have conducted studies
using nitrosoaldicarb, but discussion ofthis chemical is
beyond the scope ofthis review.
Teratogenicity and Reproductive Effects
Of the limited studies available on the subject, none
indicated any teratogenic effects associated with ex-
posure to aldicarb.
The potential of aldicarb as a teratogen was investi-
gated inratsbyWeil and Carpenter (50). Pregnantrats
were administered dosages of0, 0.04, 0.20, and 1.0 mg
aldicarb/kg body weight in the diet. The rats were fur-
ther divided into three groups: Group 1 rats were fed
aldicarb in the diet throughout pregnancy or until the
pups were weaned; Group 2 rats were administered
aldicarb from the day the vaginal plug first appeared
through the seventh day; and Group 3 received aldicarb
from days 5 through 15 ofgestation. No congenital mal-
formations werereported foranyofthetreated groups,
and body weights of both the mothers and pups were
normal. Although the 1.0 mg/kg dose level was at or
nearthe reported single dose LD50value forrats (8,16-
18), no significanteffects were observed concerningfer-
tility, gestation, viability of offspring, or lactation.
In a study conducted by the International Research
and Development Corporation (51), groups of 16 preg-
nant Dutch Belted rabbits each were administered sin-
gle daily doses of aldicarb to determine its teratogenic
potential. Treatment levels of 0, 0.1, 0.25, or 0.50 mg/
kg/daywereapplied viagavagetotherespectivegroups
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on days 7 through 27 of gestation. Fetuses were re-
moved surgically by Cesarean section on day 28 of ges-
tation and examined for teratologic effects. One spon-
taneous abortion each was reported in the 0.25 and 0.5
mg/kg/day groups. Although viable fetuses and total
implantation values were less for all treatment groups
thanforcontrols, thevaluesfellwithinhistoricalcontrol
ranges. No meaningful differences in fetal malforma-
tions or developmental variations between the control
and treated groups were reported.
The effects of aldicarb on reproductive performance
in rats were investigated in a three-generation study
(50), in which the insecticide was incorporated into the
diet of the parent generation animals at levels of 0.05
or 0.1 mg/kg/day for 84 days prior to mating. Similar
dosages were fed to subsequent generations. Progeny
(112 days old) were mated and their offspring used as
parents for the F3 generation pups. Comparison of in-
dices for fertility, gestation, viability, lactation, mean
weight of pups, and micropathology of F3 generation
weanlings and 90-day-old F3 adults revealed no statis-
tically significant differences relative to controls, nor
was food consumption affected by either dosage level.
More recently, Cambon et al. (5,52) examined fetal
and maternal brain, blood, and liver AChE activity in
rats following administration ofaldicarb. In the earlier
study (5), Cambon and his co-workers administered an-
alytical grade (99%) aldicarb to nulliparous pregnant
female Sprague-Dawley rats (3 groups of 8 each) at
dosage levels of 0.001, 0.01 or 0.1 mg/kg body weight
on day 18 of gestation. Treatments consisted of single
doses administered by gastric intubation, and the ani-
mals were killed by decapitation 1, 5, or24 hr following
treatment. Blood, brain, and liversamples ofbothdams
and fetuses were analyzed for AChE activity.
Table 3 reflects the results of this study. Signs of
poisoning were manifested within 5 min ofthe 0.1 mg/
kg administration. At this dosage level, all ofthe tissue
samples taken 1 and 5 hrfollowing treatment displayed
a significant decrease in AChE activity. A decrease in
acetylcholinesterase activity was still evident in both
maternal and fetal blood 24 hr after administration of
thehigherdosagelevels. Itshouldbenoted, astheauthors
pointed out, thatAChE activity wasinhibitedinthe fetus
just 1 hr following a dosage 1000 times lower than the
LD50 for aldicarb in the adult. This decrease was noted
in the blood, brain, and liver of the fetus, although in
adults, only the liver manifested a decrease in AChE ac-
tivity following administration of this 0.001 mg/kg dose.
Acetylcholinesterase activityinthefetus was significantly
lowered at all dosages ofaldicarb. Further, in a number
ofinstances, the inhibition ofAChE activity was greater
in fetal than matemal tissue, leading the authors to sug-
gest possible accumulation in fetal tissues.
In a subsequent study (52), Cambon et al. adminis-
tered by gastric intubation a single dose of 0.1 mg al-
dicarb/kg body weight to six nulliparous pregnant
Sprague-Dawley rats on day 18 of gestation. The rats
were killed by decapitation 1 hr after treatment. The
acetylcholinesterase enzymes from the brains ofmoth-
ers and fetuses were separated by electrophoresis on a
polyacrylamide gel and stained. The stain intensity of
thevariouselectrophoreticfractions wasthenmeasured
using a densitometer. A significant inhibition of both
material and fetal cerebral AChE was observed, as was
the caseintheir1979experiment. Theexistenceofthree
distinct isoenzymes was noted. The aldicarb treatment
resulted in a significant lowering ofthe least mobile of
the three (isoenzyme 1) in the dams. The levels of is-
oenzymes 1 and 2 were decreased in the fetuses. The
authors suggested that the greater inhibition of fetal
(when compared with maternal) brain AChE activity in
their 1979 experiment might be due to binding of the
inhibitors in the fetus for two ofthe isoenzymes, while
the same dose only decreases the first isoenzyme in the
mother. The authors concluded that this study tended
to supportthe hypothesisthatthe sensitivity difference
observed in maternal and fetal AChE to insecticides is
in the specific affinities of carbamate derivatives such
as aldicarb for each fetal and material isoenzyme.
Health Effects in Humans
Symptomsreportedforaccidental oroccupationalpoi-
soning (53-55) and controlled aldicarb human exposure
Table 3. Activity ofacetylcholinesterase in maternal and fetal tissues from rats given aldicarb by gastric intubation.'
Dose, Time after AChE units/g protein (mean ± SD) AChE units/g of organ (mean ± SD)
mg/kg dosing, hr Maternal blood Fetal blood Maternal brain Maternal liver Fetal brain Fetal liver
0 b 22.9 ± 1.47 24.0 ± 2.42 9.41 ± 1.45 5.89 ± 0.86 1.45 ± 0.06 1.75 ± 0.07
23.7 ± 1.06 17.7 ± 1.48 9.30 ± 1.70 3.70 ± 1.18 1.39 ± 0.10 1.35 ± 0.11
0.001 1 22.9 ± 1.46 21.1 ± 1.53* 8.93 ± 2.64 4.88 ± 0.82* 1.18 ± 0.15t 1.47 ± 0.12t
0.01 1 22.0 ± 2.48 17.9 ± 5.50t 8.02 ± 2.00 4.22 ± 0.49t 1.00 ± 0.lOt 1.33 ± 0.31t
5 18.7 ± 2.40t 13.2 ± 1.90t 9.50 ± 1.30 4.20 ± 0.80t 1.30 ± 0.17* 1.50 ± 0.lOt
24 20.4 ± 3.68* 13.2 ± 2.22* 8.16 ± 2.13 3.13 ± 0.72 1.19 ± 0.24* 1.03 ± 0.15t
0.10 1 16.0 ± 3.73t 12.7 ± 1.93t 6.99 ± 1.84* 2.81 ± 0.61t 0.83 ± 0.09t 1.95 ± 0.19t
5 15.3 ± 2.20t 14.5 ± 2.08t 7.48 ± 0.82t 3.55 ± 0.77t 1.07 ± 0.06t 1.55 ± 0.20*
24 22.0 ± 1.80t 13.6 ± 0.95t 8.30 ± 1.80 3.19 ± 1.25 1.25 ± 0.18 1.08 ± 0.07t
'Source: Cambon etal. (5).
bAChE activity in controls measured on day 18 and day 19 ofgestation, respectively.
*Significantly different than control value at p <0.05.
tSignificantly different than control value at p <0.001.
fSignificantly different than control value at p <0.01.
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(56) have been cholinergic in nature and have sponta-
neously subsided, generally within a 6-hr period. Clin-
ical symptoms varying in severity with the amount of
insecticide consumed and the age and general health of
the exposed individual included dizziness, skeletal mus-
cle weakness, epigastric cramping pain, diarrhea, ex-
cessive sweating, nausea, vomiting, nonreactive con-
tracted pupils, blurred vision, dyspnea, and muscle
fasciculation or convulsions. The causes of these mani-
festations are discussed inthesection ofthispaperdeal-
ing with the mechanisms oftoxicity.
Accidental Poisonings
The death ofa20-year-old farmworker who had been
loading granulated aldicarb (Temik 15G) into a hopper
was reported by Lee and Ransdell (57). After initially
workingwithout protective equipment, the workerwas
provided with a vapor respirator, goggles, and paper
coveralls and returned to his loading assignment with-
out any observable signs or symptoms ofproblems. He
was believed to have opened as many as 14 bags of
Temik, and the empty packaging was burned about 200
feet from the loading site. Approximately 2 hr after
beginning his first assignment as a pesticide loader, his
body was found in an adjacent field. Initial postmortem
procedures wereperformedwithouttheknowledge that
the victim had been working with Temik, and the im-
mediate cause of death was determined to be massive
crushingchestinjuriesfrombeingrunoverbyatractor.
Upon belated arrival of information indicating pos-
siblepesticide exposure, liver, kidney, and skinsamples
were taken for residue analysis. Residues of aldicarb,
aldicarb sulfoxide, and aldicarb sulfone were quanti-
tated using high-performance liquid chromatography
and an ultraviolet fluorescence technique. Detectable
levels of total aldicarb derivatives (aldicarb, aldicarb
sulfoxide, and aldicarb sulfone) were found in all tissues
analyzed (Table 4). The notably high concentrations of
the metabolites aldicarb sulfoxide and aldicarb sulfone
observed in the renal tissue were reported to be evi-
dence that excretion was already occurring at the time
ofdeath. Lee and Ransdell estimated the body burden,
Table 4. Residues of aldicarb and its metabolites in tissues
of an exposed farmworker.ab
Aldicarb,
Aldicarb
sulfoxide,
Aldicarb
sulfone,
Total
aldicarb
derivatives,
Tissue ppm ppm ppm ppm
Blood 0.028c 0.108 0.374 0.482
Liver 0.013 0.058 0.116 0.187
Kidney <0.002 0.261 0.422 0.683
Skin (hand) 0.492 0.157 0.174 0.823
Skin
(abdomen) 0.005 0.015 0.024c 0.020
Skin (thigh) 0.168 0.126 0.083 0.377
aSource: Adapted from Lee and Ransdell (57).
bNo explanation provided for differences in reported minimal de-
tectable levels.
cMinimal detectable level.
based upon total water distribution, to be 18.2 mg al-
dicarb, or 0.275 mg/kgbody weight, and concluded that
the toxicological analyses and circumstances surround-
ingthe accidentindicated thataldicarb intoxicationwas
a contributing factor. Since the victim was calculated
to have nearly three times the level ofblood and tissue
aldicarb known to produce cholinergic symptoms in
man, it was speculated that physical incapacitation due
to aldicarb exposure may have rendered him unable to
perform the necessary coordinated voluntary neuro-
muscular actions that might have prevented his death.
Two incidences of suspected carbamate poisoning in
Nebraska in 1977 have been reported (54,55). In both
instances, all individuals experiencing the symptoms of
carbamate intoxication had just eaten hydroponically
growncucumbers purchased atthe samemarket. Inthe
first reported incident, nine residents of a Nebraska
town suffered the onset of acute illness within 15 min
to 2.25 hr following ingestion ofhydroponic cucumbers
produced in the same local greenhouse. The nine cases
ofillness, all experienced in a2-weekperiod, werechar-
acterized by the following symptoms: diarrhea, vomit-
ing, excessive perspiration, blurred vision, abdominal
pain, dyspnea, musclefasciculation, nausea, andinsome
cases, headache and/or loss offunction ofarms andlegs.
Convulsions occurred in one case. The victims, three
males and six females, ranged in age from 7 to 80 years
and experienced symptoms of the sudden illness for 4
to 12 hr. All recovered quickly and completely. He-
matological and chemical analyses revealedresultswith
normal ranges, but cholinesterase levels were not de-
termined. Analysis of the remaining portions of the
uneaten cucumbers indicated that a carbamate was
present, but the precise species could not be identified.
In 1978, five individuals became seriously ill after
ingesting hydroponic cucumbers grown in the same
greenhouse that had been involved in the 1977 poison-
ings (54,55). Onset of symptoms occurred within 30 to
60min ofingestionofthe cucumbers. Thevictims, three
malesandtwofemalesranginginagefrom6to49years,
manifested symptoms similar to those observed in the
1977 incident, and recovery in this instance was also
rapid and complete. Analysis of cucumbers from the
supermarkets where the suspect cucumbers had been
purchasedrevealedthepresence ofaldicarb, asdidsam-
pling of materials from the greenhouse in which they
were grown. Three of four cucumbers sampled con-
tained aldicarb levels rangingfrom 6.6 to 10.7ppm, and
1.8 ppm ofaldicarb was identified in the water-nutrient
solution that nourished the greenhouse cucumber
plants.
Sexton (53) reported a case history of aldicarb poi-
soningexperiencedinamanufacturingplant. Thevictim
of the poisoning was a foreman who ran a mechanical
bagging machine for 1 day. Symptoms experienced in-
cluded nausea, dizziness, depression, weakness, tight-
ness ofchest muscles, and decrease in plasma and RBC
cholinesterase activity. The duration of symptoms was
somewhatlongerthan 6hr(exactdurationunspecified),
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andthesubjectreturnedtoworkthefollowingdaywith-
out symptoms.
In an experimental study with human subjects, three
groups of four adult males, all in good health, were
administered single oral doses of aldicarb (analytical
grade, 99.2% pure) in water solutions corresponding to
0.1, 0.05, or 0.025 mg insecticide/kg body weight (56).
Blood cholinesterase levels were monitored both before
and after dosing, and symptoms resulting from the
treatment were observed by physicians. Blood samples
were collected from all subjects 18 hr and 1 hr before
ingestion of the aldicarb, and at 1, 2, 4, and 6 hr after
dosing. A maximum dose of0.1 mg/kgbodyweight was
selected based upon the 0.1 mg/kg body weight no-ef-
fect-level determined in the 2-year rat feeding study of
Weil and Carpenter (33), while the other dosages se-
lected forthis experiment were one-halfand one-fourth
oftherat NOEL. Subjects receivingthe 0.1 mg/kgdose
manifested a variety ofcholinergic symptoms including
malaise, weakness in the arms and legs, pupils con-
tracted and nonreactive to light, epigastric cramping
pain, sweating of hands and forehead, air hunger, fre-
quent yawning, salivation, slurred speech, nausea, and
vomiting. The aldicarb-induced cholinesterase depres-
sion was reported to be rapidly reversible, and by 6 hr
afteradministration, allsymptoms haddisappeared and
the subjects were reported to feel normal again.
The author noted that the observed reduction in cho-
linesterase activity appeared to be out ofproportion to
the nature of the symptoms; two of the subjects that
received the 0.1 mg/kg dose had cholinesterase activity
values as low as 25% (31% if 1-hr predosing values are
used) oftheir pre-exposure level. It was concluded that
the radiometric method employed for cholinesterase
level analysis gives an average value for red cell and
plasma cholinesterase and may therefore yield a differ-
ent interpretation than the usual analytical procedures
that measure true acetylcholinesterase from the red
cell. Furthermore, statisticalanalysis ofthese datasug-
gests adose-related effect whenthe maximumpre-dose
control value is considered, leading to the assumption
that at lower levels ofingestion (0.002-0.004 mg/kg), a
significant depression of erythrocyte cholinesterase
would probably not occur.
Epidemiological Studies
Followingthe detection ofaldicarbinwellwatersam-
ples in Suffolk County, New York, Varma et al. con-
ducted a mail survey of families whose wells had been
tested for aldicarb (58). The prospective respondents
wererequested toreport everyfamilymemberwhohad
experienced any ofa list of20 general health problems,
and women ofreproductive age were to report the out-
come of all pregnancies as well as the health of their
children. A list of 25 randomly arranged neurological
symptomswasalsoincluded fortherespondentstoiden-
tify family members who had experienced any of the
symptoms.
The response rate to the more than 1500 question-
naires mailed was only about 20%. For a number of
reasons, only households with aldicarb water concen-
trations
- 8 ppb were used for analysis ofthe results.
Varma and his co-workers reported that the self-re-
ported problems suggested an association between cer-
tain neurologic symptoms/syndromes and the concen-
tration of aldicarb in the drinking water. The rate of
spontaneousabortions (Table5)washighamongwomen
consuming water with the highest aldicarb concentra-
tions; however, it should be noted that the same group
also had a high incidence of spontaneous abortions in
the 7 years prior to the use ofaldicarb in that farming
region. A dose-related trend in the spontaneous abor-
tion rates was observed forthe 1975-1981 period; how-
ever, the abortion rates of 10 and 22.4% for the two
study periods were not significantly different. The au-
thorsstated thatselectionandreportingbiascouldhave
influencedthesefindings, andthatdistortionatasurvey
responselevelaslowas20% couldbeaseriousproblem.
The authors concluded that the findings oftheir study
provided no conclusive evidence because: (1) the data
obtained were based upon information provided by res-
idents and not from medical records; (2) there was a
lack of gynecological histories and data from all preg-
nant women; (3) theresponse ratetothe questionnaires
mailed was very low; (4) the contamination level used
in the analysis was based in most instances on a single
water sample, and therefore, might not be indicative of
a long-term contamination level; and (5) the possible
presence of other synthetic chemicals used on the soil
could not be overruled.
Mechanisms of Toxicity
The primary mode ofaldicarb toxicity is cholinester-
ase inhibition. Carbamate insecticides are known to di-
rectly affect the enzyme acetylcholinesterase (AChE),
which is associated with the outer surface of mem-
branes. Thisresults in abuildup ofacetylcholine (ACh),
which acts on the plasma membrane to produce the
primaryexpressionofneurotoxicity(59). Itiscommonly
accepted that carbamates interfere with the ability of
AChE to break down the chemical transmitter ACh at
synaptic and myoneuraljunctions, although the precise
biochemical mechanism for this interaction remains an
object of discussion. It is known, however, that the
same mechanism ofaction is evident in both target and
nontarget organisms (6). Aldicarb and other carbamate
insecticides further cause depression of other cholin-
esterases ("pseudocholinesterases") in the red blood
cells and plasma ofhumans and othervetebrate species
(4,17,21,28,29,36,37,56), but the degree of inhibition
necessary to produce adverse effects in exposed sub-
jects is speculative and the subject ofcurrentresearch.
Various cholinesterases have also been identified in
the brain, liver, pancreas, intestine, heart, and skeletal
muscle ofmammals, and maybe distinguished from one
another, and from AChE ("true cholinesterases") by
substrate and inhibitor specificity (6,52,59). Erythro-
cyte AChE is a more appropriate indicator ofthe level
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Table 5. Reported pregnancies and spontaneous abortions among respondents to Suffolk County mail survey.a
Aldicarb concentration ranges, ppb
8-15 16-35 35-36 66+ Total/averages
1968_1974b
Women responding 31 41 36 32 140
Women reporting pregnancies 4 8 7 6 25
Total pregnancies reportedc 6 11 14 9 40
Spontaneous abortionsd 1 0 1 2 4
Percent spontaneous abortions 16.7 0.0 7.1 22.2 10.0
1975-1981e
Women responding 32 46 33 29 140
Women reporting pregnancies 9 10 9 7 35
Total pregnancies reportedc 17 19 18 13 67
Spontaneous abortionsf 1 69 2 6h 15
Percent spontaneous abortions 5.9 31.6 11.1 46.2 22.4
aSource: Modified from Varma et al. (58).
bPeriod prior to possible aldicarb exposure; concentration ranges merely denote geographic locations for comparison with 1975-1981 survey
data.
'Includes multiple pregnancies in the same individual.
dTrend of spontaneous abortions, 1968-1974; Z = 0.0742, p >0.22.
ePeriod ofpossible aldicarb exposure.
fTrend of spontaneous abortions, 1975-1981; Z = 1.912, p <0.028.
90ne woman had two spontaneous abortions (also one normal delivery in each ofthe 1968-1974 and 1975-1981 time periods).
hOne woman had two spontaneous abortions in this period; one woman had one each in the 1968-1974 and 1975-1981 periods (both also had
normal pregnancies).
of AChE in the central nervous system (CNS) than
plasma AChE. Blood ChE generally becomes markedly
depressed prior to the onset of cholinergic symptoms,
and symptoms do not usually appear until the cholin-
esterase level reaches 25% of the pre-exposure value.
A decrease of 60% in RBC AChE level warrants re-
moval from the source of exposure (60).
Signs and symptoms ofaldicarb intoxication are typ-
ically cholinergic and may be ameliorated bythe admin-
istration ofatropine sulfate (58,60). SinceAChE is pres-
ent in substantial excess at cholinergic synapses, 60 to
90% of the enzyme must be inhibited before the onset
ofcholinergic dysfunction (61). Symptoms ofAChE in-
hibitionandsubsequentaccumulation ofAChin nervous
tissue and effector organs mimic the muscarinic, nico-
tinic, and CNS actions ofACh and may be categorized
as follows (60):
1. Muscarinic Signs. The stimulation of muscarinic
receptors (which arefoundprimarilyinthe smooth mus-
cle, the heart, and exocrine glands) results in the fol-
lowing symptoms:
a. tightness in the chest and wheezing due to
bronchoconstriction;
b. increased bronchial secretions, salivation, lac-
rimation, and sweating;
c. increased gastrointestinal tone, with conse-
quent development of nausea, vomiting, ab-
dominal cramps, diarrhea, and involuntary de-
fecation;
d. frequent contraction of smooth muscle of the
bladder, resulting in involuntary urination;
e. bradycardia that can progress to heart block;
f. constriction ofthe pupils.
2.
Nicotinic Signs. The accumulation of Ach at the
endings of motor nerves to skeletal muscle and auto-
nomic ganglia results in the following symptoms:
a. Muscular effects, including easy fatigability
and mild weakness, followed by involuntary
twitching and cramps. Weakness affects the
muscles involved inrespiration and contributes
to dyspnea, hypoxemia, and cyanosis.
b. Nicotinic actions at autonomic ganglia may, in
severe intoxication, mask some ofthe muscar-
inic effects. Thus, tachyeardia caused by stim-
ulationofsympatheticgangliamayoverridethe
usual bradyeardia due to muscarinic action on
the heart. Elevation ofblood pressure and hy-
perglycemiaalsoreflectnicotinicactionatsym-
pathetic ganglia.
Without going into a lengthy discussion of the mor-
phology and function ofthe mammalian neuromuscular
system, thetransmission ofelectricalimpulses between
nerves and at myoneural junctions generally occurs
throughtherelease ofchemicaltransmitters whichbind
with specific receptors on the postsynaptic terminal or
motor end plate, respectively. As the chemical trans-
mitter, acetylcholine in certain nerve synapses and at
neuromuscularjunctions binds to the receptor sites, an
esterase(AChE)rapidlyhydrolyzestheAChintoacetyl
and choline fractions so that the stimulated nerves or
muscles are not continually excited. Essentially, aldi-
carb and other cholinesterase inhibitors in some way
prevent the breakdown ofACh and the subsequent re-
turn to a more normal or resting state for the nerve
and/or muscle cells.
As opposed to the long-lasting cholinesterase inhibi-
tion associated with organophosphate pesticides, the
carbamylation reactions involving the carbamates pro-
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FIGURE 2. In vtivo metabolism ofaldicarb.
duce toxicity of a considerably shorter and more tran-
sient duration (61). Kuhr and Dorough (6) suggest a
formula for the reaction of N-methylcarbamate insec-
ticides with acetycholinesterase:
° K,1 0 K2
HAChE + XOCNHCH3 LHACGhE XOAHHCH3
0 0
11 K3 1I
HOX + AChECNHCH3ILI3- HAChE + HOCINriGCH3 + HOX
HOH
In this process, the enzyme HAChE reacts with the
pesticide to form an intermediate complex which may:
1) dissociate to enzyme and carbamate, or2) decompose
into a stable carbamylated enzyme plus aleaving group,
which is the parent phenol, napthol or oxime (as in the
case ofaldicarb). The carbamylated enzyme is then hy-
drolyzed to generate free enzyme and methyl carbamic
acid. Itshould be noted that this reaction sequence does
not result in the destruction ofAChE, but rather in the
hydrolysis ofthe insecticide molecule itself.
During a normal nerve impulse, the AChE cleaves
the ACh molecule. When a carbamate insecticide such
as aldicarb enters the synapse, however, it competes
with ACh for the active site on the enzyme. Since the
decomposition to a carbamylated enzyme and leaving
group, as well as the hydrolysis of the carbamylated
enzyme, occur thousands oftimes slower when the ac-
tive site is occupied with the carbamate than with ACh,
the enzyme is essentially and effectively inhibited, and
the nornalcleavage ofthe ACh molecule by its esterase
would be precluded. The greater the quantity of car-
bamate present, the greater the enzyme inhibition and
concomitant reduction of ACh excitatory activity.
Reversal of this process may occur in two ways: 1)
through dissociation of the pesticide-enzyme complex,
and 2) adecarbamylation reaction, the half-life ofwhich
has been estimated to be 30 to 40 min (62,63). By these
mechanisms, ifinsecticide exposure were not continual,
recovery from anti-AChE activity would begin within
a few minutes of carbamylation and be complete (and
the associated symptoms dissipated) within a matter of
hours. This has been observed to be the case in human
exposures (54-56).
The in vivo metabolism of aldicarb transforms the
parent insecticide without activation into the sulfoxide
and sulfone cholinesterase inhibiting forms (Fig. 2).
Further illumination ofthe mechanism of sensitivity
to aldicarb was provided by Cambon et al. (52), who
observed a significant inhibition of maternal and fetal
cerebral AChE following exposure ofthe dams. These
authors described the existence ofthree distinct isoen-
zymes that were involved, and reported that the treat-
ment produced a significant lowering in the dams ofthe
least mobile ofthe three (isoenzyme 1) and a decrease
of isoenzymes 1 and 2 in the fetuses. Cambon and his
co-workers suggested that the greater inhibition ob-
served in fetal brain AChE activity in a previous study
(5) might be due to the binding ofthe inhibitors fortwo
ofthe isoenzymes in the fetuses as opposed to only the
firstisoenzyme inthemothers atthe same dosagelevel,
thereby indicating a greater affinity of the carbamate
derivatives, such as aldicarb, for each respective fetal
and maternal isoenzyme.
Conclusions
The primary mode of toxic action of aldicarb is cho-
linesteraseinhibition. Reportsofonedeathandmultiple
accidental poisonings in humans indicate relatively
rapid remission ofsymptoms, unless the exposure is so
severe as to result in a life threatening situation and
death. To date, aldicarb has been found to exhibit no
carcinogenicactivity, butthepotentialforinvivotrans-
fonnation to the nitroso derivative (which is carcino-
genic) hasbeensuggested as alikelypossibility. Recent
positive mutagenicity studies suggest that this insec-
ticide has mutagenic properties, but other negative
studies make an unequivocal determination of muta-
genic potential inappropriate at this time. No terato-
genic or long-term toxic effects as a result of aldicarb
exposure have been reported.
279O280 RISHER, MINK, AND STARA
We gratefully acknowledge the technical and typing support pro-
vided by Carol Haynes in the preparation of this manuscript.
REFERENCES
1. Knaak, J. B., Tallant, M. J., and Sullivan, L. J. The metabolism
of 2-methyl-2-(methylthio)propionaldehyde O-(methyl-carba-
moyl)oxime in the rat. J. Agr. Food Chem. 14: 573-578 (1966).
2. Andrawes, N. R., Dorough, H. W., and Lindquist, D. A. Deg-
radation and elimination ofTemik in rats. J. Econ. Entomol. 60:
979-987 (1967).
3. Dorough, H. W., and Ivie, G. W. Temik-S' metabolism in a
lactating cow. J. Agr. Food Chem. 16: 460-464 (1968).
4. Dorough, H. W., Davis, R. B., and Ivie, G. W. Fate of Temik-
carbon-14 in lactating cows during a 14-day feeding period. J.
Agr. Food Chem. 18: 135-142 (1970).
5. Cambon, C., Declume, C., and Derache, R. Effect of the insec-
ticidal carbamate derivatives (carbofuran, primicarb, aldicarb) in
the activity ofacetylcholinesterase in tissues from pregnant rats
and fetuses. Toxicol. Appl. Pharmacol. 49: 203-208 (1979).
6. Kuhr, R. J., and Dorough, H. W. Carbamate Insecticides: Chem-
istry, Biochemistry, andToxicology. CRCPress, Inc., Cleveland,
OH, 1976, pp. 2-6, 103-112, 187-190, 211-213, 219-220.
7. Martin, H., and Worthing, C. R., Eds. Pesticide Manual. British
Crop Protection Council, Worcestershire, England, 1977, p. 6.
8. Gaines, T. B. Acute toxicity of pesticides. Toxicol. Appl. Phar-
macol. 14: 515-534 (1969).
9. Bull, D. L., Lindquist, D. A., and Coppedge, J. R. Metabolism
of 2-methyl-2(methyl-thio)propionaldehyde O-(methyl-carba-
moyl)oxime in insects. J. Agr. Food Chem. 15: 610-616 (1967).
10. National Academy of Sciences. Drinking Water and Health.
Washington, DC, 1977, pp. 635-643.
11. Wilkinson, C. F., Babish, J. G., Lemley, A. T., and Soderlund,
D. M. A toxicological evaluation of aldicarb and its metabolites
in relation to the potential human health impact of aldicarb res-
idues in Long Island ground water. Report prepared by Com-
mittee from the Institute for Comparative and Environmental
Toxicology. Cornell University, Ithaca, NY, 1983.
12. Oonnithan, E. S., and Casida, J. E. Oxidation of methyl- and
dimethyl-carbamate insecticide chemicalsbymicrosomalenzymes
and anticholinesterase activity of the metabolites. J. Agr. Food
Chem. 16: 29-44 (1967).
13. Knaack, J. R. Biological and nonbiological modifications of car-
bamates. Bull. WHO 44: 121-131 (1971).
14. HaJjar, N. P., and Hodgson, E. Sulfoxidation of thioether-con-
taining pesticides by the flavin-adenine dinucleotide-dependent
monooxygenase ofpiglivermicrosomes. Biochem. Pharmacol. 31:
745-752 (1982).
15. Marshall, T. C., and Dorough, H. W. Biliary excretion of car-
bamate insecticides in the rat. Pestic. Biochem. Physiol. 11: 56-
63 (1979).
16. Striegel, J. A., and Carpenter, C. P. Range finding tests on
compound 21149. Mellon Institute unpublished report 25-53
(1962).
17. Carpenter, C. P., and Smyth, H. F. Recapitulation of pharma-
codynamic and acute toxicity studies on Temik. Mellon Institute
unpublished report 28-78 (1965).
18. Weiden, M. H.J., Moorefield, H. H., andPayne, L. K. O-(methyl-
carbamoyl) oximes: a class of carbamate insecticides-acaricides.
J. Econ. Entomol. 58: 154-155 (1965).
19. Weil, C. S. Mellon Institute unpublished report 31-48 (1968).
(Cited in U.S. EPA, 1975.)
20. Weil, C. S. Miscellaneous toxicity studies. Mellon Institute un-
published report 35-41 (1973).
21. Weil, C. S., and Carpenter, C. P. Temik and other materials.
Miscellaneous single doseperoral andparenteralLD50assaysand
some joint action studies. Mellon Institute unpublished report
33-7 (1970). (Cited in U.S. EPA, 1975).
22. Black, A. L., Chiu, Y. C., Fahmy, M. A. H., and Fukuto, T. R.
Selective toxicity of N-sulfenylated derivatives of insecticidal
methylcarbamate esters. J. Agr. Food Chem. 21: 747-751 (1973).
23. West, J., and Carpenter, C. Miscellaneous acute toxicity data.
Mellon Institute unpublished report 28-140 (1966).
24. Carpenter, C. P., and Smyth, H. F. Temik 10G. 15-Day dermal
applications to rabbits. Mellon Institute unpublished report 29-
80 (1966).
25. Weil, C. S., and Carpenter, C. P. Temik10G. Acuteandfourteen-
day dermal applications to rabbits. Mellon Institute unpublished
report 31-137 (1968). (Cited in Wilkinson et al., 1983).
26. Schafer, E. W., Jr., and Bowles, W. A., Jr. Acute oral toxicity
and repellency of 933 chemicals to house and deer mice. Arch.
Environ. Contain. Toxicol. 14: 119-129 (1985).
27. Weil, C. S., and Carpenter, C. P. Results of three months of
inclusion ofCompound 21149 in the diet ofrats. Mellon Institute
unpublished report 26-47 (1963).
28. Nycum, J. S., and Carpenter, C. P. Summary with respect to
Guideline PR70-15. Mellon Institute unpublished report 31-48
(1970).
29. DePass, L. R., Weaver, E. V., and Mirro, E. J. Aldicarb sulf-
oxide/aldicarb sulfone mixture in drinking water of rats: effects
on growth and acetylcholinesterase activity. J. Toxicol. Environ.
Health 16: 163-172 (1985).
30. Wills, J. H. The measurement and significance ofchanges in the
cholinesterase activities of erythrocytes and plasma in man and
animals. CRC Crit. Rev. Toxicol. 1: 153-202 (1972).
31. Spieresburg, Th.J., Zoun, P. E. F., Doorenbos, F. W., andWan-
ningen, H. Eengeval van aldicarb-vergiftiging bijrunduee.
Tijdschr. Diergeneesk D. 110: 555-558. (Dutch with English ab-
stract).
32. Pozzani, U. C., and Carpenter, C. P. Response ofrats living for
28 days on topsoil treated with UC-21149 10G-1. Mellon Institute
unpublished report 29-2 (1966).
33. Weil, C. S., and Carpenter, C. P. Two-yearfeedingofcompound
21149 in the diet ofrats. Mellon Institute unpublished report 28-
123 (1965).
34. Weil, C. S., and Carpenter, C. P. Aldicarb (A), aldicarb sulfoxide
(ASO), aldicarb sulfone (AS02) and a 1:1 mixture ofASO:AS02.
Two-yearfeedinginthe dietofrats. Mellon Institute unpublished
report 35-82 (1972).
35. Weil, C. S., and Carpenter, C. P. Two-year feedingofCompound
21149 inthe diet ofdogs. Mellon Institute unpublished report29-
5 (1966).
36. Weil, C. S., and Carpenter, C. P. Temik sulfoxide. Results of
feeding in the diet of rats for six months and dogs for three
months. Mellon Institute unpublished report 31-141 (1968).
37. Weil, C. S., and Carpenter, C. P. Temik sulfone. Results offeed-
ing in the diet ofrats for six months and dogs for three months.
Mellon Institute unpublished report 31-142 (1968).
38. Smyth, H. n.d. (Cited in U.S. EPA, 1975).
39. FAO/WHO (Food and Agricultural Organization/World Health
Organization). Pesticide residues infood: Reportofthe 1979Joint
Meeting of the FAO Panel of Experts on Pesticide Residues in
Food and the Environment and the WHO Expert Group on Pes-
ticide Residues, FAO Plant Production and Protection Ser. No.
20. Rome, 1980.
40. U.S. Environmental Protection Agency. Substitute Chemical
Program: Initial scientific and mini-economic review ofaldicarb.
EPA 540/1-75-013. NTIS PB-243-743, 1975.
41. Weil, C. S., and Carpenter, C. P. Results oflong-term tests for
mouse skin carcinogenicity ofthree process residues, oneepoxide
and three compounds. Mellon Institute unpublished report29-34
(1966).
42. National Cancer Institute. Bioassay of aldicarb for possible car-
cinogenicity. NCI-CG-TR-136. U.S. DHEW, PHS, National In-
stitute of Health, 1979.
43. Quarles, J. M., Sega, M. W., Schenley, C. K., and Lijinsky, W.
Transformation ofhamster fetal cells by nitrosated pesticides in
a transplacental assay. Cancer Res. 39: 4525-4533 (1979).
44. Cid, M. G., and Matos, E. Induction of sister-chromatid ex-
changes in cultured humanlymphocytes byaldicarb, acarbamate
pesticide. Mut. Res. 138: 175-179 (1984).
45. Sharaf, A. A., Temtamy, S. A., DeHondt, H. A., Belal, M. H.,
and Kassam, E. A. Effect of aldicarb (Temik) a carbamate in-
secticide, onchromosomes ofthelaboratory rat. Egypt. J. Genet.
Cytol. 11: 143-152 (1982).
46. Well, C. S., and Carpenter, C. P. Aldicarb inclusion is the dietTHE TOXIC EFFECTS OF THE INSECTICIDE ALDICARB 281
of rats for three generations and a dominant lethal mutagenesis
test. Mellon Institute unpublished report 37-90 (1974).
47. Ercegovich, D. C., and Rashid, K. A. Mutagenesis induced in
mutant strains of Salmonella typhimurium by pesticides. Ab-
stracts ofpapers. Am. Chem. Soc., p. 43 (1973).
48. Blevins, D., Lijinsky, W., and Regan, J. D. Nitrosated methyl-
carbamate insecticides: effect on the DNA ofhuman cells. Mut.
Res. 44: 1-7 (1977).
49. Seller, P. Nitrosation in vitro and in vivo by sodium nitrite, and
mutagenicity of nitrogenous pesticides. Mut. Res. 48: 225-236
(1977).
50. Weil, C. S., and Carpenter, C. P. Results ofa three-generation
reproduction study on rats fed compound 21149 in their diet.
Mellon Institute unpublished report 27-158 (1964).
51. International Research and Development Corporation. Teratol-
ogy study in rabbits. Union Carbide Corporation, 1983.
52. Cambon, C., Declume, C., and Derache, R. Fetal and maternal
rat brain acetylcholinesterase: isoenzymes changes following in-
secticidal carbamate derivatives poisoning. Arch. Toxicol. 45:
257-262 (1980).
53. Sexton W. F. Report on aldicarb (1966). (Cited in U.S. EPA,
1975).
54. Center for Disease Control. Epidemiologic notes and reports:
Suspected carbamate intoxications-Nebraska. Morbid. Mortal.
Week. Rep. 28: 133-134 (1979).
55. Goes, E. H., Savage, E. P., Gibbons, G., Aaronson, M., Ford,
S.A., and Wheeler, S.G. Suspected foodborne carbamate pesti-
cide intoxications associated with ingestion of hydroponic cuc-
umbers. Am. J. Epidemiol. 111: 254-259 (1980).
56. Haines, R. G. Ingestion ofaldicarb by human volunteers: a con-
trolled study ofthe effect ofaldicarb onman. Unpublished report
with addendum. Union Carbide Corporation, 1971.
57. Lee, M. H., and Ransdell, J. F. A farmworker death due to
pesticide toxicity: A case report. J. Toxicol. Environ. Health 14:
239-246 (1984).
58. Varma, A. O., Zaki, M., and Sterman, A. B. Results ofaprelim-
inary survey. School ofMedicine, State University ofNew York
at Stony Brook and Dept. Health Services, County of Suffolk,
NY, 1983.
59. Blum, K., and Manzo, L., Eds. Neurotoxicology. Marcel Dekker,
Inc., New York, 1985, p. 406.
60. Abou-Donia, M. B. Biochemical toxicology oforganophosphorous
compounds. In: Neurotoxicology (K. Blum and L. Manzo, Eds.),
Marcel Dekker, Inc., New York, 1985, pp. 423-444.
61. Doull, J., Klassen, C. D., and Amdur, M. O., Eds. Casarett and
Doull's Toxicology: The Basic Science of Poisons, 2nd ed. Mac-
Millan Publishing Co., Inc., New York, 1980, pp. 375-379.
62. O'Brien, R. D. Insecticide Action and Metabolism. Academic
Press, New York, 1967.
63. Reiner, E., and Aldridge, W. N. Effects ofpH on inhibition and
spontaneous reactivation ofacetylcholinesterase treated with es-
ters ofphosphonic acids and ofcarbamic acids. Biochem. J. 105:
171 (1967).